T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
W.P. Carey
WPC
$16.1B
| $7.9M | ﹤0.01% |
115,528
+17,208
| +18% | +$1.41M |
|
1102
Organon & Co
OGN
$3.59B
| $7.89M | ﹤0.01% |
337,205
-4,078
| -1% | -$123K |
|
1103
Plug Power
PLUG
$3.21B
| $7.89M | ﹤0.01% |
375,412
-13,459
| -3% | -$321K |
|
|
ZEN
1104
DELISTED
ZENDESK INC
ZEN
| $7.81M | ﹤0.01% |
102,660
+558
| +0.5% | +$42.3K |
|
1105
DXC Technology
DXC
$1.71B
| $7.8M | ﹤0.01% |
318,435
+11,271
| +4% | +$310K |
|
1106
Berkshire Hathaway Class A
BRK.A
$1.09T
| $7.72M | ﹤0.01% |
19
| – | – |
|
|
SASR
1107
DELISTED
Sandy Spring Bancorp Inc
SASR
| $7.67M | ﹤0.01% |
217,356
-2,769,203
| -93% | -$109M |
|
1108
Ferguson
FERG
$47.4B
| $7.62M | ﹤0.01% |
74,042
+637
| +0.9% | +$74.3K |
|
1109
Palantir
PLTR
$430B
| $7.61M | ﹤0.01% |
936,330
+49,736
| +6% | +$442K |
|
|
SPLK
1110
DELISTED
Splunk Inc
SPLK
| $7.6M | ﹤0.01% |
101,030
+4,529
| +5% | +$444K |
|
1111
PennyMac Financial
PFSI
$4B
| $7.54M | ﹤0.01% |
175,842
-4,764,733
| -96% | -$249M |
|
1112
Armstrong World Industries
AWI
$7.75B
| $7.52M | ﹤0.01% |
94,896
-750
| -0.8% | -$63.5K |
|
1113
Silicon Laboratories
SLAB
$7.3B
| $7.51M | ﹤0.01% |
60,847
+2,165
| +4% | +$289K |
|
|
ARNC
1114
DELISTED
Arconic Corporation
ARNC
| $7.47M | ﹤0.01% |
438,573
-229,348
| -34% | -$5.95M |
|
1115
Liberty Broadband Class C
LBRDK
$5.07B
| $7.44M | ﹤0.01% |
100,840
-5,258
| -5% | -$559K |
|
1116
Vir Biotechnology
VIR
$1.52B
| $7.44M | ﹤0.01% |
385,609
+209,070
| +118% | +$5.31M |
|
1117
RB Global
RBA
$16B
| $7.41M | ﹤0.01% |
118,655
-5,003
| -4% | -$340K |
|
1118
Consensus Cloud Solutions
CCSI
$695M
| $7.41M | ﹤0.01% |
156,605
-991
| -0.6% | -$51K |
|
|
EQRX
1119
DELISTED
EQRx, Inc. Common Stock
EQRX
| $7.32M | ﹤0.01% |
1,478,340
+48,586
| +3% | +$245K |
|
1120
Relmada Therapeutics
RLMD
$507M
| $7.28M | ﹤0.01% |
196,556
+27,799
| +16% | +$770K |
|
1121
Centrus Energy
LEU
$3.69B
| $7.23M | ﹤0.01% |
176,360
+161,500
| +1,087% | +$6.21M |
|
1122
Mueller Water Products
MWA
$4.09B
| $7.2M | ﹤0.01% |
700,983
-7,237,058
| -91% | -$84.3M |
|
1123
Orchestra BioMed
OBIO
$266M
| $7.18M | ﹤0.01% |
724,565
-2,637
| -0.4% | -$26.1K |
|
1124
Trinity Capital Inc.
TRIN
$1.73B
| $7.16M | ﹤0.01% |
570,968
+55,031
| +11% | +$812K |
|
1125
Markel Group
MKL
$22.8B
| $7.14M | ﹤0.01% |
6,589
-832
| -11% | -$1.02M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.